Physician profile
Arooj Fatima
NPI 1720437338
$484.75
in general payments reported to CMS, 2019-2025
7 companies · $18.48 in 2025
The $18.48 reported for 2025 was less than what a typical Nephrology (Internal Medicine) provider received nationally (typical 2025 total: $311).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $232 · 2021: $36.21 · 2022: $164 · 2023: $33.61 · 2025: $18.48.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $33.61 · Education: $18.48.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $33.61 |
| Education | $18.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $287.66 | 2020-2022 | |
| Medtronic, INC. | $67.80 | 2022 | |
| Calliditas Therapeutics US INC. | $57.05 | 2022-2023 | Tarpeyo |
| Otsuka America Pharmaceutical, INC. | $24.67 | 2021 | |
| Amgen INC. | $18.48 | 2025 | Tavneos |
| Opko Pharmaceuticals, LLC | $17.55 | 2022 | |
| Abbott Laboratories | $11.54 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arooj Fatima listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.